Pharsight Forms Drug Development Alliances With AstraZeneca, Quintiles

Jul 01, 1999

Premium

MOUNTAIN VIEW, Calif.--Pharsight, a clinical drug development software provider and consultancy here, has formed two partnerships: one with AstraZeneca R&D Molndal, of Sweden, and a broader one with Quintiles Transnational, a Research Triangle Park, NC-based provider of product development and commercialization services to the pharmaceutical industry.

The goal of the AstraZeneca alliance is to jointly deploy Pharsight's trial design software and methodologies for drug development to AstraZeneca's clinical development processes in a specific therapeutic area.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

Years and Years

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Diving Evolution

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

This Week in Science

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

Issues to Overcome

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.

Jun

12

Featured Webinar

Bridging the Gap Between Testing and Treatment in Precision Oncology

This webinar will highlight a comprehensive end-to-end solution for precision care in oncology, comprising sample acquisition through to sequencing and analysis, treatment recommendations, and follow-through.

Main menu